diallyl trisulfide has been researched along with mocetinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Cao, J; Li, S; Lin, G; Wang, K; Zhang, F; Zhang, Y; Zhao, Z; Zhu, X | 1 |
| Han, W; Jiang, L; Li, M; Wang, S; Wang, X; Xie, K | 1 |
| Chen, Y; Fu, R; Li, X; Liu, C; Liu, Y; Ma, C; Qu, D; Tao, L; Tu, S; Zhao, Y | 1 |
3 other study(ies) available for diallyl trisulfide and mocetinostat
| Article | Year |
|---|---|
Diallyl trisulfide inhibits naphthalene-induced oxidative injury and the production of inflammatory responses in A549 cells and mice.
Topics: Allyl Compounds; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line, Tumor; Female; Inflammation; Inflammation Mediators; Male; Mice; Naphthalenes; NF-kappa B; Nitric Oxide; Oxidative Stress; Peroxidase; Reactive Oxygen Species; Sulfides; Superoxide Dismutase | 2015 |
The protective effect of diallyl trisulfide on cytopenia induced by benzene through modulating benzene metabolism.
Topics: Activation, Metabolic; Allyl Compounds; Animals; Benzene; Blotting, Western; Catalysis; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Erythrocyte Count; Erythrocytes; Glutathione Transferase; Leukocyte Count; Leukocytes; Liver; Male; NAD(P)H Dehydrogenase (Quinone); Peroxidase; Rats, Sprague-Dawley; Sulfides; Urinalysis | 2018 |
Extracellular Microparticles Encapsulated with Diallyl Trisulfide Interfere with the Inflammatory Tumor Microenvironment and Lung Metastasis of Invasive Melanoma.
Topics: Allyl Compounds; Animals; Calgranulin A; Cell Line, Tumor; Cell Movement; Epithelial Cells; Extracellular Vesicles; Fibronectins; Inflammation; Interleukin-6; Lung; Lung Neoplasms; Melanoma; Mice; Peroxidase; Sulfides; Toll-Like Receptor 4; Tumor Microenvironment | 2021 |